Study: Residents Successfully Taking Risperdal Should Stay On It

Despite a recent push by regulators and LTC groups to reduce the use of antipsychotics in nursing homes, researchers are cautioning that taking residents off Risperdal might actually do more harm than good.

The study, published in the New England Journal of Medicine, noted that when dementia care residents were switched from taking Risperdal to taking a placebo, they were twice as likely to relapse compared to residents who remained on the medication. Additionally, the researchers found that the rates of side effects or death were not any higher in those who continued taking Risperdal.

To learn more, click here.